EPN
Pharmaceuticals, Biotechnology & Life Sciences
Epsilon Healthcare
- Short interest
- 0.01%
- +0.01 pp 30d
- as of 5 June 2023
- Reported shorts
- 22.2K
- Shares on issue
- 300.354M
Epsilon Healthcare (EPN) company profile
Profile, insiders and operations
Company
AI-generated research profile of Epsilon Healthcare
Pharmaceuticals
Biotechnology
Medicinal Cannabis
Healthcare Services
Manufacturing
Epsilon Healthcare (EPN) is a diversified global healthcare and pharmaceuticals company operating in the ASX market. The company owns significant medicinal cannabis assets, including the largest cannabis manufacturing facility in the Southern Hemisphere, positioning it as a key player in this emerging sector. Beyond cannabis, EPN provides a range of medical equipment, supplies, and healthcare services, offering hi-tech products and turn-key solutions to the healthcare industry.
Director trades
20 trades recorded
EPN intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required